CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		33,499,953
Beginning balance at Dec. 31, 2020	$ 210,918	$ 3	$ 364,248	$ 599	$ (153,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of options (in shares)		186,633
Common stock issued upon exercise of options	1,595		1,595
Issuance of common stock for vesting of restricted stock units (in shares)		851,741
Shares withheld for payroll taxes related to vesting of restricted stock units (in shares)		(268,867)
Shares repurchased for withholding tax on restricted stock units	(13,945)		(13,945)
Issuance of common stock under cashless warrant exercise (in shares)		418,633
Issuance of common stock under investor warrant exercise (in shares)		3,367,647
Issuance of common stock under investor warrant exercise	56,778		56,778
Issuance of common stock in connection with offering, net of offering costs (in shares)		5,526,861
Issuance of common stock in connection with offering, net of offering costs	309,782	$ 1	309,781
Issuance of common stock in connection with business combinations (in shares)		1,035,756
Issuance of common stock in connection with business combinations	53,611		53,611
Stock-based compensation expense	5,006		5,006
Net (loss) income	13,416				13,416
Foreign currency translation gain (loss)	$ (1,981)			(1,981)
Ending balance (in shares) at Dec. 31, 2021	44,618,357	44,618,357
Ending balance at Dec. 31, 2021	$ 635,180	$ 4	777,074	(1,382)	(140,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of options (in shares)	8,283	8,283
Common stock issued upon exercise of options	$ 75		75
Issuance of common stock for vesting of restricted stock units (in shares)		818,489
Issuance of common stock for vesting of restricted stock units	1	$ 1
Shares withheld for payroll taxes related to vesting of restricted stock units (in shares)		(247,979)
Shares repurchased for withholding tax on restricted stock units	(2,461)		(2,461)
Issuance of common stock under cashless warrant exercise (in shares)		99
Stock-based compensation expense	8,354		8,354
Net (loss) income	(285,415)				(285,415)
Foreign currency translation gain (loss)	$ (5,853)			(5,853)
Ending balance (in shares) at Dec. 31, 2022	45,197,249	45,197,249
Ending balance at Dec. 31, 2022	$ 349,881	$ 5	$ 783,042	$ (7,235)	$ (425,931)